99mtc mdp
Small moleculeexperimentalImaging agent
Clinical trial activity
7 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
2
Earliest trial started Jan 1, 2015 (NCT02304757)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc mdp
- 99mtc mdp
- 99tc-mdp
- 99tc-mdp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05924672 | Phase 2 | Dec 18, 2023 | Bayer, University of California, San Francisco |
| NCT05614518 | Phase 3 | Mar 29, 2021 | — |
| NCT05000086 | Phase 4 | Jun 1, 2019 | Chinese Academy of Medical Sciences, Government of China |
| NCT03948191 | Phase 4 | Oct 16, 2017 | Dalian Medical University |
| NCT02993029 | N/A | Jan 1, 2017 | Huazhong University of Science and Technology, Jiao Tong University |
| NCT03002454 | Phase 3 | Aug 1, 2016 | University of Manitoba, Winnipeg Regional Health Authority |
| NCT02304757 | N/A | Jan 1, 2015 | Jiao Tong University |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiao Tong University | Academic/Hospital | 2 | 2 | 1 | 2015 |
| Bayer | For profit | 1 | 0 | 1 | 2023 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Dalian Medical University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Government of China | Government | 1 | 0 | 1 | 2019 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Manitoba | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Winnipeg Regional Health Authority | Government | 1 | 0 | 1 | 2016 |
9 organizations
Page 1 / 1